Genomic backgrounds and aberrant activation of metabolic pathways, such as pathways related to inflammation or angiogenesis, are just some of the important factors that need to be considered for cancer patients’ stratification. Metabolomics enables, accelerates, and supports Immuno-Oncology pipeline development through phenotypic and immune-metabolic biomarker discovery, thus facilitating a more personalized medicine approach.
Join us for our upcoming Lunch & Learn session to learn more!
- Metabolomic Profiling Identifies Specific Human Gut Microbiota Metabolites and Additional Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
- Knockout of Putative Tumor Suppressor Aldh1l1 in Mice Reprograms Metabolism to Accelerate Growth of Tumors in a Diethyl nitrosamine (DEN) Model of Liver Carcinogenesis
The 15-20 minute case studies session shall be followed by a 15 minute Q&A session.